pharmaceutical-investing InMed Announces Results of 2025 Annual General and Special Meeting 17 December 2025
pharmaceutical-investing InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901 18 November 2025